These nanocarriers demonstrated effective blood–brain barrier penetration and modulation of chromosome region maintenance 1 (CRM1)-mediated PKM2 nuclear translocation in microglia, a critical pathway in AD pathology. Here, PKM is linked to Alzheimer disease.